The number of contacts with the ombudsman increased 11 percent from 2010 and nearly doubled from the 250 inquiries made in 2009. Nearly two-thirds of the contacts came from within the industry with others coming from consumers (23 percent), healthcare providers (7 percent) and internal employees (5 percent).
Related Articles on the FDA:
FDA Announces 2012 Medical Device Strategic Priorities
FDA Approves Genzyme Framingham Manufacturing Plant
FDA Clears Medtronic’s Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
